US Stock MarketDetailed Quotes

Axsome Therapeutics (AXSM)

Watchlist
  • 185.490
  • -1.490-0.80%
Trading Jan 23 12:32 ET
9.35BMarket Cap-39.72P/E (TTM)

Axsome Therapeutics (AXSM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
105.61%1.05M
-7.68%-32.42M
18.88%-43.38M
11.49%-128.41M
13.70%-26.2M
65.21%-18.63M
45.60%-30.11M
-818.52%-53.47M
-24.52%-145.08M
-10.15%-30.36M
Net income from continuing operations
26.89%-47.23M
39.54%-47.97M
13.08%-59.41M
-20.05%-287.22M
24.06%-74.91M
-3.86%-64.6M
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
Operating gains losses
--0
----
----
----
----
----
----
----
----
----
Depreciation and amortization
16.98%2.41M
12.69%2.25M
16.49%2.13M
16.45%7.96M
19.14%2.07M
18.24%2.06M
18.00%1.99M
10.17%1.83M
55.25%6.83M
2.84%1.74M
Other non cash items
-18.84%13.98M
-347.10%-7.36M
330.25%746K
-40.24%31.73M
-73.19%11.85M
1,572.14%17.22M
-59.95%2.98M
-177.33%-324K
1,000.44%53.1M
878.29%44.21M
Change In working capital
74.72%8.78M
-162.63%-14.33M
-49.10%-10.15M
219.40%33.9M
273.69%12.8M
156.09%5.03M
272.97%22.88M
29.29%-6.81M
-219.95%-28.39M
-79.49%3.43M
-Change in receivables
161.75%2.32M
-97.96%-37.43M
-193.21%-19.4M
17.40%-47.18M
-9.14%-17.91M
65.89%-3.75M
16.40%-18.91M
6.75%-6.62M
-51.52%-57.12M
5.70%-16.41M
-Change in inventory
-422.63%-6.93M
-866.10%-4.05M
-23.87%-1.2M
45.34%-2.44M
-130.81%-4.14M
-23.45%2.15M
150.19%528K
78.01%-972K
15.41%-4.46M
60.45%-1.8M
-Change in prepaid assets
-115.28%-3.45M
-247.77%-331K
-2.86%-4.03M
27.59%-3.86M
208.81%1.43M
-80.52%-1.6M
131.55%224K
-61.86%-3.92M
-95.06%-5.34M
-307.74%-1.32M
-Change in payables and accrued expense
104.54%16.85M
-33.05%27.47M
208.28%14.48M
126.82%87.38M
45.65%33.41M
6,488.80%8.24M
268.00%41.04M
9.03%4.7M
-44.47%38.53M
-41.11%22.94M
Cash from discontinued investing activities
Operating cash flow
105.61%1.05M
-7.68%-32.42M
18.88%-43.38M
11.49%-128.41M
13.70%-26.2M
65.21%-18.63M
45.60%-30.11M
-818.52%-53.47M
-24.52%-145.08M
-10.15%-30.36M
Investing cash flow
Cash flow from continuing investing activities
35.56%-58K
75.00%-13K
-244.90%-338K
53.61%-270K
-328.57%-30K
75.74%-90K
60.90%-52K
-38.03%-98K
98.92%-582K
96.13%-7K
Net PPE purchase and sale
35.56%-58K
75.00%-13K
-244.90%-338K
53.61%-270K
-328.57%-30K
75.74%-90K
60.90%-52K
-38.03%-98K
17.09%-582K
96.13%-7K
Net business purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Cash from discontinued investing activities
Investing cash flow
35.56%-58K
75.00%-13K
-244.90%-338K
53.61%-270K
-328.57%-30K
75.74%-90K
60.90%-52K
-38.03%-98K
98.92%-582K
96.13%-7K
Financing cash flow
Cash flow from continuing financing activities
-30.05%21.27M
140.24%34.54M
2,565.88%29.27M
-82.53%57.84M
712,300.00%14.24M
-8.89%30.41M
-94.16%14.38M
-102.30%-1.19M
16.32%331.01M
-100.19%-2K
Net issuance payments of debt
-113.50%-664K
-1,247.31%-2.51M
-146.01%-401K
-101.16%-990K
---330K
---311K
-100.62%-186K
-100.30%-163K
88.89%85M
--0
Net common stock issuance
-24.08%9.95M
189.71%32.63M
--19.65M
-84.24%40.78M
--16.42M
-61.18%13.1M
--11.26M
--0
6.15%258.75M
--0
Proceeds from stock option exercised by employees
-23.49%15.52M
72.99%11.66M
581.13%17.04M
147.04%30.68M
0.26%1.15M
370.00%20.29M
2.60%6.74M
546.25%2.5M
98.67%12.42M
-59.53%1.15M
Net other financing activities
-32.26%-3.54M
-110.58%-7.25M
-98.98%-7.01M
49.78%-12.63M
-160.94%-2.99M
43.05%-2.68M
77.79%-3.44M
7.77%-3.53M
-141.14%-25.16M
34.94%-1.15M
Cash from discontinued financing activities
Financing cash flow
-30.05%21.27M
140.24%34.54M
2,565.88%29.27M
-82.53%57.84M
712,300.00%14.24M
-8.89%30.41M
-94.16%14.38M
-102.30%-1.19M
16.32%331.01M
-100.19%-2K
Net cash flow
Beginning cash position
-4.00%303.02M
-9.21%300.91M
-18.34%315.35M
92.29%386.19M
-21.42%327.34M
-27.79%315.66M
34.45%331.44M
92.29%386.19M
132.26%200.84M
83.09%416.56M
Current changes in cash
90.48%22.26M
113.34%2.11M
73.62%-14.44M
-138.22%-70.84M
60.53%-11.99M
156.86%11.68M
-108.28%-15.78M
-219.88%-54.75M
62.06%185.35M
-13.84%-30.37M
End cash Position
-0.63%325.27M
-4.00%303.02M
-9.21%300.91M
-18.34%315.35M
-18.34%315.35M
-21.42%327.34M
-27.79%315.66M
34.45%331.44M
92.29%386.19M
92.29%386.19M
Free cash flow
105.28%988K
-7.54%-32.44M
18.39%-43.71M
11.66%-128.68M
13.62%-26.23M
65.28%-18.72M
45.64%-30.16M
-809.11%-53.57M
-24.27%-145.66M
-9.46%-30.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 105.61%1.05M-7.68%-32.42M18.88%-43.38M11.49%-128.41M13.70%-26.2M65.21%-18.63M45.60%-30.11M-818.52%-53.47M-24.52%-145.08M-10.15%-30.36M
Net income from continuing operations 26.89%-47.23M39.54%-47.97M13.08%-59.41M-20.05%-287.22M24.06%-74.91M-3.86%-64.6M-18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M
Operating gains losses --0------------------------------------
Depreciation and amortization 16.98%2.41M12.69%2.25M16.49%2.13M16.45%7.96M19.14%2.07M18.24%2.06M18.00%1.99M10.17%1.83M55.25%6.83M2.84%1.74M
Other non cash items -18.84%13.98M-347.10%-7.36M330.25%746K-40.24%31.73M-73.19%11.85M1,572.14%17.22M-59.95%2.98M-177.33%-324K1,000.44%53.1M878.29%44.21M
Change In working capital 74.72%8.78M-162.63%-14.33M-49.10%-10.15M219.40%33.9M273.69%12.8M156.09%5.03M272.97%22.88M29.29%-6.81M-219.95%-28.39M-79.49%3.43M
-Change in receivables 161.75%2.32M-97.96%-37.43M-193.21%-19.4M17.40%-47.18M-9.14%-17.91M65.89%-3.75M16.40%-18.91M6.75%-6.62M-51.52%-57.12M5.70%-16.41M
-Change in inventory -422.63%-6.93M-866.10%-4.05M-23.87%-1.2M45.34%-2.44M-130.81%-4.14M-23.45%2.15M150.19%528K78.01%-972K15.41%-4.46M60.45%-1.8M
-Change in prepaid assets -115.28%-3.45M-247.77%-331K-2.86%-4.03M27.59%-3.86M208.81%1.43M-80.52%-1.6M131.55%224K-61.86%-3.92M-95.06%-5.34M-307.74%-1.32M
-Change in payables and accrued expense 104.54%16.85M-33.05%27.47M208.28%14.48M126.82%87.38M45.65%33.41M6,488.80%8.24M268.00%41.04M9.03%4.7M-44.47%38.53M-41.11%22.94M
Cash from discontinued investing activities
Operating cash flow 105.61%1.05M-7.68%-32.42M18.88%-43.38M11.49%-128.41M13.70%-26.2M65.21%-18.63M45.60%-30.11M-818.52%-53.47M-24.52%-145.08M-10.15%-30.36M
Investing cash flow
Cash flow from continuing investing activities 35.56%-58K75.00%-13K-244.90%-338K53.61%-270K-328.57%-30K75.74%-90K60.90%-52K-38.03%-98K98.92%-582K96.13%-7K
Net PPE purchase and sale 35.56%-58K75.00%-13K-244.90%-338K53.61%-270K-328.57%-30K75.74%-90K60.90%-52K-38.03%-98K17.09%-582K96.13%-7K
Net business purchase and sale --------------0------------------0----
Cash from discontinued investing activities
Investing cash flow 35.56%-58K75.00%-13K-244.90%-338K53.61%-270K-328.57%-30K75.74%-90K60.90%-52K-38.03%-98K98.92%-582K96.13%-7K
Financing cash flow
Cash flow from continuing financing activities -30.05%21.27M140.24%34.54M2,565.88%29.27M-82.53%57.84M712,300.00%14.24M-8.89%30.41M-94.16%14.38M-102.30%-1.19M16.32%331.01M-100.19%-2K
Net issuance payments of debt -113.50%-664K-1,247.31%-2.51M-146.01%-401K-101.16%-990K---330K---311K-100.62%-186K-100.30%-163K88.89%85M--0
Net common stock issuance -24.08%9.95M189.71%32.63M--19.65M-84.24%40.78M--16.42M-61.18%13.1M--11.26M--06.15%258.75M--0
Proceeds from stock option exercised by employees -23.49%15.52M72.99%11.66M581.13%17.04M147.04%30.68M0.26%1.15M370.00%20.29M2.60%6.74M546.25%2.5M98.67%12.42M-59.53%1.15M
Net other financing activities -32.26%-3.54M-110.58%-7.25M-98.98%-7.01M49.78%-12.63M-160.94%-2.99M43.05%-2.68M77.79%-3.44M7.77%-3.53M-141.14%-25.16M34.94%-1.15M
Cash from discontinued financing activities
Financing cash flow -30.05%21.27M140.24%34.54M2,565.88%29.27M-82.53%57.84M712,300.00%14.24M-8.89%30.41M-94.16%14.38M-102.30%-1.19M16.32%331.01M-100.19%-2K
Net cash flow
Beginning cash position -4.00%303.02M-9.21%300.91M-18.34%315.35M92.29%386.19M-21.42%327.34M-27.79%315.66M34.45%331.44M92.29%386.19M132.26%200.84M83.09%416.56M
Current changes in cash 90.48%22.26M113.34%2.11M73.62%-14.44M-138.22%-70.84M60.53%-11.99M156.86%11.68M-108.28%-15.78M-219.88%-54.75M62.06%185.35M-13.84%-30.37M
End cash Position -0.63%325.27M-4.00%303.02M-9.21%300.91M-18.34%315.35M-18.34%315.35M-21.42%327.34M-27.79%315.66M34.45%331.44M92.29%386.19M92.29%386.19M
Free cash flow 105.28%988K-7.54%-32.44M18.39%-43.71M11.66%-128.68M13.62%-26.23M65.28%-18.72M45.64%-30.16M-809.11%-53.57M-24.27%-145.66M-9.46%-30.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More